Sermorelin dosage chart

Reconstitution steps

1. 1Draw 3.0 mL bacteriostatic water with a sterile syringe.
2. 2Inject slowly down the vial wall; gently swirl to dissolve (do not shake vigorously).
3. 3Label with reconstitution date and refrigerate at 2–8 °C (36–46 °F), protected from light.
4. 4Wipe vial stopper with alcohol before each use; use a new sterile needle and syringe for each injection.

Important Notes

Practical considerations for consistency, safety, and optimal response.

• Bedtime dosing is critical: Sermorelin works best when administered before sleep to align with the natural nocturnal GH pulse.
• Use new sterile insulin syringes; dispose in a designated sharps container after each use.
• Rotate injection sites systematically (abdomen, thighs, upper arms) to prevent irritation or lipohypertrophy.
• Inject slowly subcutaneously; wait a few seconds before withdrawing the needle to ensure full delivery.
• Monitor IGF‑1 levels at baseline and periodically (every 1–2 months) to confirm response and adjust dosing if needed.
• Check thyroid function if using long‑term, as subclinical hypothyroidism can blunt GH response.
• Document daily dose, time, and injection site in a log for adherence and troubleshooting.

How This Works

Sermorelin is a synthetic analog of growth hormone–releasing hormone (GHRH) that binds to GHRH receptors on pituitary somatotropes, stimulating endogenous pulsatile GH secretion. Unlike exogenous GH administration, sermorelin preserves physiologic feedback loops—GH release is subject to normal negative feedback via somatostatin and IGF‑1, reducing the risk of excessive GH or IGF‑1 levels. This pulsatile GH output then promotes hepatic and peripheral IGF‑1 production, supporting anabolic processes such as protein synthesis, lipolysis, and tissue repair. Pediatric studies in idiopathic GH deficiency demonstrated significant improvements in height velocity over 6–12 months of nightly subcutaneous therapy at 30 µg/kg. In adults, off‑label use aims to restore age‑related declines in GH output, though robust adult trial data are limited and dosing is extrapolated from pediatric and physiologic studies. Sermorelin requires a functional pituitary to be effective and will not work in cases of pituitary damage or primary GH gene defects.

Potential Benefits & Side Effects

Observations from pediatric clinical trials and adult off‑label research.

• Stimulates endogenous pulsatile GH release, supporting physiologic IGF‑1 elevation.
• In pediatric GH deficiency: significant improvements in height velocity and growth parameters over 6–12 months.
• In adults (off‑label): may support favorable changes in body composition, energy, recovery, and metabolic markers (evidence limited; effects more modest than direct GH therapy).
• Preserves physiologic feedback, reducing risk of supraphysiologic GH or IGF‑1 levels compared to exogenous GH.
• Injection‑site reactions (most common): Transient redness, pain, or swelling at injection site (~17% incidence in trials).
• Rare systemic effects (<1%): Headache, flushing, dizziness, hyperactivity, drowsiness, or hives.
• Thyroid considerations: ~6.5% of patients developed subclinical hypothyroidism in one study; untreated hypothyroidism can blunt GH response.
• No serious acromegaly, hypoglycemia, or excessive IGF‑1 elevations reported at recommended dosages (built‑in negative feedback prevents overshooting).

Lifestyle Factors

Complementary strategies to optimize GH response and overall outcomes.

• Sleep quality: Prioritize 7–9 hours of uninterrupted sleep nightly to maximize natural GH pulse and sermorelin efficacy.
• Nutrition: Consume adequate protein (1.6–2.2 g/kg/day) to support anabolic processes; avoid high‑carbohydrate meals immediately before bedtime (can blunt GH release).
• Exercise: Combine resistance training (3–5×/week) and moderate aerobic activity to amplify GH/IGF‑1 benefits on muscle mass, fat loss, and metabolic health.
• Stress management: Chronic stress elevates cortisol, which can suppress GH secretion; practice stress‑reduction techniques (meditation, yoga, adequate rest).
• Avoid alcohol and smoking: Both can impair GH release and blunt sermorelin response.

Injection Technique

General subcutaneous guidance from clinical best‑practice resources.

• Gather materials: Reconstituted sermorelin vial, new insulin syringe (with needle attached), alcohol swab, cotton ball or bandage.
• Choose injection site: Abdomen (at least 2 inches from navel), outer thigh, upper outer arm, or buttocks—areas with subcutaneous fat layer.
• Rotate sites: Use a systematic rotation to prevent irritation or lipoatrophy; do not inject into the exact same spot each time (keep at least 1–2 inches apart).
• Clean vial stopper and skin: Swab vial stopper with alcohol; clean injection site with alcohol swab in 2‑inch diameter; allow to dry completely.
• Draw dose: Remove needle cap; draw air equal to dose volume; inject air into vial; invert and draw prescribed dose; expel air bubbles.
• Pinch and insert: Pinch a fold of skin; insert needle at 45–90° angle (depending on needle length and fat thickness) into subcutaneous tissue. Do not aspirate for subcutaneous injections.
• Inject: Slowly depress plunger over a couple of seconds; wait 1–2 seconds before withdrawing needle at same angle.
• Post‑injection: Apply gentle pressure with cotton ball or alcohol pad; do not rub the site. If slight bleeding, apply bandage.
• Dispose: Immediately dispose of needle and syringe in designated sharps container; never recap needle.
• Pain or lumps: Ensure injecting into fatty tissue (not too shallow into skin or too deep into muscle); rotate sites consistently.
• Injection‑site reactions: Mild redness/swelling is common (~17%); give that area a longer break before reusing.
• Cold solution discomfort: Let refrigerated vial warm to room temperature for ~30 minutes before injection (optional).

important-note

This content is intended for therapeutic educational purposes only and does not constitute medical advice, diagnosis, or treatment. Sermorelin is for research use only. Always consult a qualified healthcare professional before starting any peptide protocol. Individual responses vary; dosing and duration should be tailored to specific health status, goals, and monitoring (including IGF‑1 and thyroid function). This information is not intended to replace professional medical guidance.

Sermorelin dosage FAQs